Cure Today: Antiangiogenic gene therapy

May 26, 2016

A novel antiangiogenic gene therapy, added to another antiangiogenic agent, Avastin (bevacizumab), led to significantly better overall survival (OS) in recurrent glioblastoma multiforme (GBM) compared with historical patients treated with Avastin alone, a small phase 2 trial showed. Read the full story at Cure Today




Stock Transcript: VeroScience supports DeFronzo’s research

May 26, 2016

VeroScience LLC, is pleased to announce that independent research conducted by Dr. Ralph DeFronzo and his team at UT Health Science Center at San Antonio (“Health Science Center“) has continued to delineate metabolic targets of VeroScience’s Cycloset® in reducing hyperglycemia in type 2 diabetes mellitus (T2DM) patients. The study has also identified positive influences of the […]


Runner’s World: Running Back From Hell

May 25, 2016

PTSD is shattering the lives of thousands of American soldiers. But some experts believe running can counter the disorder’s debilitating symptoms and help restore the joy that war erased. Read the full story at Runner’s World


KSAT 12: Fat hormones used to treat PTSD

May 25, 2016

There could be a new type of treatment for people suffering from post-traumatic stress disorder, according to a researcher at the University of Texas Health Science Center in San Antonio. Read the full story at KSAT 12